Number of the records: 1
synukleinopatie
SYS d000080874 LBL 00000cx^^^2200181-^^45^^ 005 20240119201446.4 100 $a 20200101asloy0103 ba0 152 $b mesh 250 $a synukleinopatie $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo 300 1-
$a 2020 $8 eng 300 1-
$a Neurodegenerative Diseases (1998-2019) $8 eng 300 1-
$a alpha-Synuclein (1999-2019) $8 eng 330 1-
$a Neurodegenerative disorders involving deposition of abnormal ALPHA-SYNUCLEIN in dopaminergic neurons and glial cells in the brain. Pathological aggregations of alpha-synuclein proteins results in LEWY BODIES and Lewy neurites; melanin granules in the SUBSTANTIA NIGRA and LOCUS COERULEUS; and glial cytoplasmic inclusions. Synucleinopathies are associated with mutation in the ALPHA-SYNUCLEIN (SNCA) gene on chromosome 4. PARKINSON DISEASE; LEWY BODY DISEASE with dementia; and MULTIPLE SYSTEM ATROPHY are prominent examples of synucleinopathy. $8 eng 450 $a a-Synucleinopathies $5 e $8 eng 450 $a alpha Synuclein Pathology $5 e $8 eng 450 $a alpha-Synucleinopathies $5 e $8 eng 450 $a a-synukleinopatie $5 e $8 slo 450 $a alfa-synukleínopatie $5 e $8 slo 450 $a patológia alfa-synukleínu $5 e $8 slo 450 $a patológia alfa-synukleínová $5 e $8 slo 450 $a alfa-synukleinopatie $5 e $8 slo 550 $3 sllk_un_auth*d016631 $Y Lewy Bodies $5 F $a Lewyho telieska 550 $3 sllk_un_auth*d051844 $Y alpha-Synuclein $5 F $a alfa-synukleín 550 $3 sllk_un_auth*d016631 $Y Lewy Bodies $5 B $a Lewyho telieska 550 $3 sllk_un_auth*d051844 $Y alpha-Synuclein $5 B $a alfa-synukleín 686 $a C10.574.928 686 $a C18.452.845.650 750 $a Synucleinopathies $8 eng 801 -0
$a SK $b BA006 $c 20200216 801 -2
$a SK $b BA006 $c 20200608 801 -2
$a SK $b BA006 $c 20211115 801 -2
$a SK $b BA006 $c 20231120 980 $x M
Number of the records: 1